Panion today announced that the Board of Panion Animal Health AB (”Panion” or ”Company”) on 28 November 2018, with the authorization of the Annual General Meeting of 29 May 2018, decided to issue a new issue of 7,687,374 shares with preferential rights for existing...
Link (locked article) >> Redistributed with permission from Animal Pharm Panion targets gene therapy pilot study in North America Panion Animal Health will soon enter a pilot study for its canine epilepsy drug candidate. The Swedish company is developing a gene...
